| Organism name | Patersonia spp. | 
|---|---|
| Genus | Patersonia | 
| Family | Iridaceae | 
| Kingdom | Plantae | 
| Linked NCBI taxonomy name | Patersonia | 
|---|---|
| Linked NCBI taxonomy ID | 58967 | 
| Linked level | genus | 
| Family in NCBI taxonomy | Iridaceae | 
|---|---|
| ID | 26339 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae | 
|---|---|
| ID | 33090 | 
| Plant class | Liliopsida | 
|---|---|
| ID | 4447 | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00005548   | Narcissin / Isorhamnetin 3-O-rutinoside | CHEMBL84174 CHEMBL258394 CHEMBL1711509 CHEMBL2165403 | C031062 | 7 / 1 / 2 | No. 1 | No. 15 |   | |
| C00005372   | Hyperin / Hyperoside / Quercetin 3-O-galactoside / Quercetin 3-O-beta-D-galactoside / Quercetin 3-beta-galactopyranoside / Quercetin 3-O-beta-D-galactopyranoside | CHEMBL33027 CHEMBL309323 CHEMBL250450 CHEMBL251254 CHEMBL457304 CHEMBL1098724 CHEMBL2337335 CHEMBL2337336 | C021304 | 38 / 43 / 34 | 4 / 0 | No. 2 | No. 15 |   | 
| C00005525   | Isorhamnetin 3-glucoside / Isorhamnetin 3-O-glucoside / Isorhamnetin 3-O-beta-D-glucoside / Isorhamnetin 3-O-beta-D-glucopyranoside | CHEMBL234316 CHEMBL516621 | 1 / 1 / 0 | No. 2 | No. 15 |   | ||
| C00005374   | Quercetin | CHEMBL82242 CHEMBL479232 CHEMBL1437696 | C012526 | 14 / 2 / 2 | 2 / 1 | No. 2 | No. 15 |   | 
| C00005728   | Myricetin 3-galactoside / Myricetin 3-O-galactoside | CHEMBL462244 CHEMBL1221722 | No. 2 | No. 15 |   | |||
| C00005729   | Myricetin 3-glucoside / Myricetin 3-O-beta-D-glucoside / Myricetin 3-O-beta-D-glucopyranoside | CHEMBL462244 CHEMBL1221722 | No. 2 | No. 15 |   | |||
| C00005730   | Myricitrin / Myricetin 3-O-rhamnoside / Myricetin 3-O-alpha-L-rhamnoside / Myricetin 3-O-alpha-L-rhamnopyranoside | CHEMBL454576 CHEMBL522983 CHEMBL1599224 | C008577 | 25 / 11 / 11 | No. 2 | No. 15 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| Q9UNA4 | DNA polymerase iota | Enzyme | C00005372 C00005374 C00005548 C00005730 | 0 / 0 | 
| P07237 | Protein disulfide-isomerase | Enzyme | C00005372 C00005374 C00005548 C00005730 | 0 / 0 | 
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00005372 C00005374 C00005730 | 0 / 0 | 
| P39748 | Flap endonuclease 1 | Enzyme | C00005372 C00005374 C00005730 | 0 / 0 | 
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00005372 C00005374 C00005730 | 0 / 0 | 
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00005372 C00005374 C00005730 | 0 / 0 | 
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00005372 C00005374 C00005730 | 0 / 0 | 
| Q9Y253 | DNA polymerase eta | Enzyme | C00005372 C00005374 C00005730 | 1 / 1 | 
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00005372 C00005730 | 1 / 1 | 
| P34949 | Mannose-6-phosphate isomerase | Enzyme | C00005372 C00005730 | 1 / 1 | 
| P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00005372 C00005525 | 1 / 0 | 
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00005372 C00005374 | 1 / 1 | 
| P06746 | DNA polymerase beta | Enzyme | C00005372 C00005730 | 0 / 0 | 
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00005372 C00005730 | 0 / 0 | 
| Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00005372 C00005730 | 1 / 0 | 
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00005372 C00005730 | 0 / 0 | 
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00005374 C00005730 | 0 / 0 | 
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00005374 C00005730 | 0 / 0 | 
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00005372 C00005730 | 0 / 1 | 
| O75496 | Geminin | Unclassified protein | C00005372 C00005548 | 0 / 0 | 
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00005372 C00005730 | 1 / 4 | 
| P15121 | Aldose reductase | Enzyme | C00005372 C00005374 | 0 / 0 | 
| Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00005374 C00005730 | 0 / 0 | 
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00005372 C00005730 | 4 / 3 | 
| P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00005372 | 3 / 1 | 
| P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00005372 | 0 / 0 | 
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00005548 | 0 / 0 | 
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00005730 | 0 / 0 | 
| P14679 | Tyrosinase | Oxidoreductase | C00005372 | 4 / 2 | 
| P06280 | Alpha-galactosidase A | Enzyme | C00005372 | 1 / 1 | 
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00005372 | 0 / 0 | 
| P10696 | Alkaline phosphatase, placental-like | Enzyme | C00005372 | 0 / 1 | 
| Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00005372 | 2 / 0 | 
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00005548 | 0 / 0 | 
| P03372 | Estrogen receptor | NR3A1 | C00005548 | 1 / 1 | 
| P35372 | Mu-type opioid receptor | Opioid receptor | C00005372 | 0 / 0 | 
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00005548 | 0 / 1 | 
| P41143 | Delta-type opioid receptor | Opioid receptor | C00005372 | 0 / 0 | 
| P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00005372 | 1 / 1 | 
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00005372 | 0 / 0 | 
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00005372 | 0 / 0 | 
| P02545 | Prelamin-A/C | Unclassified protein | C00005372 | 11 / 10 | 
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00005730 | 0 / 0 | 
| P04062 | Glucosylceramidase | Enzyme | C00005372 | 6 / 4 | 
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00005372 | 0 / 3 | 
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00005730 | 0 / 0 | 
| Q99700 | Ataxin-2 | Unclassified protein | C00005730 | 1 / 1 | 
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00005730 | 1 / 1 | 
| Q16637 | Survival motor neuron protein | Unclassified protein | C00005372 | 4 / 1 | 
| Q9NPH5 | NADPH oxidase 4 | Enzyme | C00005372 | 0 / 0 | 
| Q9P1W9 | Serine/threonine-protein kinase pim-2 | Pim | C00005374 | 0 / 0 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | C00005374 | 
| 1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | C00005374 | 
| 581 | BAX, BCL2L4 | BCL2-associated X protein | C00005372 | 
| 54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic | C00005372 | 
| 2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 | C00005372 | 
| 23411 | SIRT1, SIR2L1 | sirtuin 1 | C00005372 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #103470 | Albinism, ocular, with sensorineural deafness | P14679 | 
| #203100 | Albinism, oculocutaneous, type ia; oca1a | P14679 | 
| #606952 | Albinism, oculocutaneous, type ib; oca1b | P14679 | 
| #614490 | Blood group, junior system; jr | Q9UNQ0 | 
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a | P02545 | 
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism | P02545 | 
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 | P02545 | 
| #602579 | Congenital disorder of glycosylation, type ib; cdg1b | P34949 | 
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 | P02545 | 
| #615363 | Estrogen resistance; estrr | P03372 | 
| #301500 | Fabry disease | P06280 | 
| #600274 | Frontotemporal dementia; ftd | P10636 | 
| #608013 | Gaucher disease, perinatal lethal | P04062 | 
| #230800 | Gaucher disease, type i | P04062 | 
| #230900 | Gaucher disease, type ii | P04062 | 
| #231000 | Gaucher disease, type iii | P04062 | 
| #231005 | Gaucher disease, type iiic | P04062 | 
| #232300 | Glycogen storage disease ii | P10253 | 
| #610140 | Heart-hand syndrome, slovenian type | P02545 | 
| #176670 | Hutchinson-gilford progeria syndrome; hgps | P02545 | 
| #146300 | Hypophosphatasia, adult | P05186 | 
| #241510 | Hypophosphatasia, childhood | P05186 | 
| #241500 | Hypophosphatasia, infantile | P05186 | 
| #601626 | Leukemia, acute myeloid; aml | P36888 | 
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 | P02545 | 
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada | P02545 | 
| #613205 | Muscular dystrophy, congenital, lmna-related | P02545 | 
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b | P02545 | 
| #160900 | Myotonic dystrophy 1; dm1 | Q9NR56 | 
| #168600 | Parkinson disease, late-onset; pd | P04062 | 
| #260540 | Parkinson-dementia syndrome | P10636 | 
| #614674 | Periodic fever, menstrual cycle-dependent | P08908 | 
| #172700 | Pick disease of brain | P10636 | 
| #601399 | Platelet disorder, familial, with associated myeloid malignancy | Q01196 | 
| #275210 | Restrictive dermopathy, lethal | P02545 | 
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 | P14679 | 
| #253300 | Spinal muscular atrophy, type i; sma1 | Q16637 | 
| #253550 | Spinal muscular atrophy, type ii; sma2 | Q16637 | 
| #253400 | Spinal muscular atrophy, type iii; sma3 | Q16637 | 
| #271150 | Spinal muscular atrophy, type iv; sma4 | Q16637 | 
| #183090 | Spinocerebellar ataxia 2; sca2 | Q99700 | 
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 | Q9NUW8 | 
| #601104 | Supranuclear palsy, progressive, 1; psnp1 | P10636 | 
| #138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 | Q9UNQ0 | 
| #278300 | Xanthinuria, type i | P47989 | 
| #278750 | Xeroderma pigmentosum, variant type; xpv | Q9Y253 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00264 | Charcot-Marie-Tooth disease (CMT) | P02545
                            (related) | 
| H00294 | Dilated cardiomyopathy (DCM) | P02545
                            (related) | 
| H00420 | Familial partial lipodystrophy (FPL) | P02545
                            (related) | 
| H00563 | Emery-Dreifuss muscular dystrophy | P02545
                            (related) | 
| H00590 | Congenital muscular dystrophies (CMD/MDC) | P02545
                            (related) | 
| H00593 | Limb-girdle muscular dystrophy (LGMD) | P02545
                            (related) | 
| H00601 | Hutchinson-Gilford progeria syndrome | P02545
                            (related) | 
| H00663 | Restrictive dermopathy | P02545
                            (related) | 
| H00665 | Mandibuloacral dysplasia | P02545
                            (related) | 
| H01216 | Left ventricular noncompaction (LVNC) | P02545
                            (related) | 
| H00026 | Endometrial Cancer | P03372
                            (marker) | 
| H00066 | Lewy body dementia (LBD) | P04062
                            (related) | 
| H00126 | Gaucher disease | P04062
                            (related) | 
| H00426 | Defects in the degradation of ganglioside | P04062
                            (related) | 
| H00810 | Progressive myoclonic epilepsy (PME) | P04062
                            (related) | 
| H00213 | Hypophosphatasia | P05186
                            (related) | 
| H00125 | Fabry disease | P06280
                            (related) | 
| H00036 | Osteosarcoma | P08684
                            (marker) | 
| H00069 | Glycogen storage diseases (GSD) | P10253
                            (related) | 
| H00058 | Amyotrophic lateral sclerosis (ALS) | P10636
                            (related) | 
| H00077 | Progressive supranuclear palsy (PSP) | P10636
                            (related) | 
| H00078 | Frontotemporal lobar degeneration (FTLD) | P10636
                            (related) | 
| H00023 | Testicular cancer | P10696
                            (marker) | 
| H00168 | Oculocutaneous albinism (OCA) | P14679
                            (related) | 
| H00038 | Malignant melanoma | P14679
                            (marker) | 
| H00118 | Congenital disorders of glycosylation (CDG) type I | P34949
                            (related) | 
| H00017 | Esophageal cancer | P35354
                            (related) | 
| H00025 | Penile cancer | P35354
                            (related) | 
| H00046 | Cholangiocarcinoma | P35354
                            (related) | 
| H00003 | Acute myeloid leukemia (AML) | P36888
                            (related) Q01196 (related) Q01196 (marker) Q13951 (marker) | 
| H00192 | Xanthinuria | P47989
                            (related) | 
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) | Q01196
                            (related) Q01196 (marker) | 
| H00004 | Chronic myeloid leukemia (CML) | Q01196
                            (related) | 
| H00978 | Thrombocytopenia (THC) | Q01196
                            (related) | 
| H00455 | Spinal muscular atrophy (SMA) | Q16637
                            (related) | 
| H00063 | Spinocerebellar ataxia (SCA) | Q99700
                            (related) Q9NUW8 (related) | 
| H00403 | Disorders of nucleotide excision repair | Q9Y253
                            (related) |